Bristol-Myers Squibb Co (MEX:BMY) Cyclically Adjusted Book per Share: MXN249.67 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:BMY Bristol-Myers Squibb Co MEX:BMY
70 GF Score
Price MXN1,075.00
GF Value MXN908.39
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bristol-Myers Squibb Co Cyclically Adjusted Book per Share?

Bristol-Myers Squibb Co MEX:BMY +1.65% 70 Cyclically Adjusted Book per Share is MXN249.67 as of Mar. 2026. GuruFocus rates MEX:BMY with a GF Score™ of 70/100 and a GF Value™ of MXN908.39 (Modestly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted book value per share for the three months ended in Mar. 2026 was MXN177.242. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN249.67 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bristol-Myers Squibb Co's average Cyclically Adjusted Book Growth Rate was 1.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 2.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 5.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Bristol-Myers Squibb Co was 10.80% per year. The lowest was 2.10% per year. And the median was 5.40% per year.

As of today (2026-07-24), Bristol-Myers Squibb Co's current stock price is MXN1075.00. Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was MXN249.67. Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio of today is 4.31.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bristol-Myers Squibb Co was 8.72. The lowest was 2.70. And the median was 5.33.


Bristol-Myers Squibb Co  (MEX:BMY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1075.00/249.67
=4.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bristol-Myers Squibb Co was 8.72. The lowest was 2.70. And the median was 5.33.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Bristol-Myers Squibb Co Cyclically Adjusted Book per Share Related Terms


Bristol-Myers Squibb Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co Cyclically Adjusted Book per Share Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 258.67 269.51 246.17 308.95 264.36

Bristol-Myers Squibb Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 292.36 281.43 273.23 264.36 249.67

MEX:BMY vs PFE, GILD, AMGN: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio falls into.


MEX:BMY
70GF Score
Bristol-Myers Squibb Co MEX:BMY
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bristol-Myers Squibb Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bristol-Myers Squibb Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=177.242/330.2130*330.2130
=177.242

Current CPI (Mar. 2026) = 330.2130.

Bristol-Myers Squibb Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 165.116 241.018 226.221
201609 180.637 241.428 247.066
201612 200.433 241.432 274.138
201703 164.765 243.801 223.164
201706 162.019 244.955 218.411
201709 163.916 246.819 219.299
201712 141.900 246.524 190.072
201803 142.192 249.554 188.150
201806 148.310 251.989 194.349
201809 156.314 252.439 204.473
201812 169.642 251.233 222.972
201903 180.472 254.202 234.436
201906 188.464 256.143 242.963
201909 213.840 256.759 275.016
201912 436.777 256.974 561.261
202003 517.222 258.115 661.695
202006 502.762 257.797 643.989
202009 490.337 260.280 622.083
202012 338.746 260.474 429.441
202103 344.262 264.877 429.180
202106 329.731 271.696 400.747
202109 344.728 274.310 414.982
202112 342.497 278.802 405.653
202203 295.336 287.504 339.208
202206 307.188 296.311 342.334
202209 309.091 296.808 343.878
202212 291.839 296.797 324.697
202303 273.156 301.836 298.837
202306 262.394 305.109 283.983
202309 248.335 307.789 266.427
202312 247.181 306.746 266.091
202403 135.013 312.332 142.742
202406 153.782 314.175 161.632
202409 166.403 315.301 174.273
202412 167.904 315.605 175.676
202503 174.788 319.799 180.480
202506 161.320 322.561 165.147
202509 167.116 324.800 169.901
202512 163.389 324.054 166.494
202603 177.242 330.213 177.242

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of MXN249.67 mean?
Bristol-Myers Squibb Co (MEX:BMY) has a Cyclically Adjusted Book per Share of MXN249.67 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bristol-Myers Squibb Co and its competitors.
Is Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share too high?
Bristol-Myers Squibb Co's current Cyclically Adjusted Book per Share is MXN249.67. Overall, Bristol-Myers Squibb Co has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share compare to PFE and GILD?
Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share of MXN249.67 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bristol-Myers Squibb Co and its competitors. Bristol-Myers Squibb Co's current Cyclically Adjusted Book per Share is MXN249.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bristol-Myers Squibb Co stock overvalued right now?
Based on GuruFocus' analysis, Bristol-Myers Squibb Co (MEX:BMY) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN908.39, compared to a current price of MXN1,075.00 — trading 18.3% above its estimated fair value. The current Cyclically Adjusted Book per Share is MXN249.67. Bristol-Myers Squibb Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Bristol-Myers Squibb Co (MEX:BMY), the current Cyclically Adjusted Book per Share is MXN249.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bristol-Myers Squibb Co (MEX:BMY) Overvalued in 2026?

Based on GuruFocus' analysis, Bristol-Myers Squibb Co stock appears to be overvalued. The current stock price of MXN1,075.00 is trading 18.3% above its estimated GF Value™ of MXN908.39. GuruFocus considers Bristol-Myers Squibb Co to be Modestly Overvalued.

Key valuation signals for MEX:BMY:

  • Cyclically Adjusted Book per Share: MXN249.67
  • GF Value™: MXN908.39 vs. price of MXN1,075.00 (18.3% above fair value)
  • GF Score™: 70/100 with 7 warning signs

No single metric tells the full story. See the MEX:BMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bristol-Myers Squibb Co Business Description

Address Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
70GF Score

Get the complete analysis for MEX:BMY

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,075.00
Price
MXN908.39
GF Value